Table 1.
Characteristics | HPV 16* | HPV 18* | ||
n | % | n | % | |
Age (years) | ||||
Median | 39 | 39 | ||
Range | 9.27 | 8.77 | ||
≤30 | 5 | 9.3 | 3 | 11.5 |
30–50 | 39 | 72.2 | 19 | 73.1 |
>50 | 10 | 18.5 | 4 | 15.4 |
Clinical stage (FIGO) | ||||
IB1 | 46 | 85.2 | 22 | 84.6 |
IB2 | 8 | 14.8 | 4 | 15.4 |
Histological type | ||||
Squamous cell carcinoma | 46 | 85.2 | 22 | 84.6 |
Adenocarcinoma | 5 | 9.3 | 2 | 7.7 |
Adenosquamous cell carcinoma | 3 | 5.6 | 2 | 7.7 |
Others | 0 | 0 | 0 | 0 |
Grade of differentiation | ||||
Grade I | 1 | 2 | 1 | 4.2 |
Grade II | 33 | 66 | 17 | 70.8 |
Grade III | 16 | 32 | 6 | 25 |
Metastases to lymph nodes | ||||
Yes | 3 | 5.6 | 3 | 12 |
No | 51 | 94.4 | 22 | 88 |
Angiolymphatic invasion | ||||
Yes | 12 | 28.6 | 5 | 25 |
No | 30 | 71.4 | 75 | 75 |
Initial treatment | ||||
Surgery alone | 42 | 77.8 | 20 | 76.9 |
Surgery + radiotherapy | 9 | 16.7 | 4 | 15.4 |
Radiotherapy + surgery | 3 | 5.6 | 2 | 7.7 |
Recurrence of the disease | ||||
Yes | 5 | 9.8 | 3 | 12 |
No | 46 | 90.2 | 22 | 88 |
Treatment of recurrence | ||||
Radiotherapy | 0 | 0 | 0 | 0 |
Chemotherapy | 1 | 100 | 1 | 100 |
Radiotherapy + chemotherapy | 0 | 0 | 0 | 0 |
HPV-positive patients.